← Leaderboards
Natasha Kay Stout
Beth Israel Deaconess Medical Center
$5,808,801
Attributed
$16,015,650
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,015,650 · 5
By mechanism
U01$8,840,248 · 1
R01$7,023,674 · 3
F32$151,728 · 1
Top collaborators
- Oguzhan Alagoz8 shared
- Harry De Koning8 shared
- Xuelin Huang8 shared
- Sandra J Lee8 shared
- Jeanne Mandelblatt8 shared
- Sylvia Katina Plevritis8 shared
- Amy Trentham-Dietz8 shared
- Mara A Schonberg4 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Mara A Schonberg$11,353,717
- Matthew R Reynolds$688,134
- David J Cohen$2,555,982
- Rebecca Luckett$1,026,248
- Lisa I Iezzoni$7,160,507
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsWomanMalignant Breast NeoplasmScreeningMammographyBreast DensityModels And SimulationMammographic ScreeningBaseBreast Cancer Risk FactorMortalityGuidelinesCancer Intervention And Surveillance Modeling NetworkFundingCessation Of LifeFutureCostBiopsyBreastIncidenceBreast ImagingPerformanceRaceRisk Factors
Grant awards (23)
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum Administrative Supplement$566,636
U01 · FY2025 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,508,560
U01 · FY2024 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,791,871
U01 · FY2023 · CA
A Conversation Aid on Mammography Screening to Support Shared Decision Making between Clinicians and Women Aged 75 and Older$555,111
R01 · FY2023 · AG
Identifying effective risk-based supplemental ultrasound screening strategies for women with dense breasts$649,400
R01 · FY2022 · CA
A Conversation Aid on Mammography Screening to Support Shared Decision Making between Clinicians and Women Aged 75 and Older$592,758
R01 · FY2022 · AG
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$503,760
U01 · FY2022 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum - Supplement$34,980
U01 · FY2022 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,967,606
U01 · FY2021 · CA
A Conversation Aid on Mammography Screening to Support Shared Decision Making between Clinicians and Women Aged 75 and Older$691,576
R01 · FY2021 · AG
Identifying effective risk-based supplemental ultrasound screening strategies for women with dense breasts$674,979
R01 · FY2021 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$503,760
U01 · FY2021 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,963,075
U01 · FY2020 · CA
Identifying effective risk-based supplemental ultrasound screening strategies for women with dense breasts$757,232
R01 · FY2020 · CA
A Conversation Aid on Mammography Screening to Support Shared Decision Making between Clinicians and Women Aged 75 and Older$734,789
R01 · FY2020 · AG
Advanced Breast Imaging: Trends and Outcomes Associated with Recent Breast Density Reporting Legislation$528,386
R01 · FY2020 · CA · contact PI
Estimating the impact of mammography screening disruptions during the COVID-19 pandemic$180,000
R01 · FY2020 · CA
Advanced Breast Imaging: Trends and Outcomes Associated with Recent Breast Density Reporting Legislation$508,845
R01 · FY2019 · CA · contact PI
Advanced Breast Imaging: Trends and Outcomes Associated with Recent Breast Density Reporting Legislation$545,874
R01 · FY2018 · CA · contact PI
Advanced Breast Imaging: Trends and Outcomes Associated with Recent Breast Density Reporting Legislation$604,724
R01 · FY2017 · CA · contact PI
Modeling Breast Carcinoma In Situ: Implications for Prevention and Control$52,504
F32 · FY2009 · CA · contact PI
Modeling Breast Carcinoma In Situ: Implications for Prevention and Control$50,428
F32 · FY2008 · CA · contact PI
Modeling Breast Carcinoma In Situ: Implications for Prevention and Control$48,796
F32 · FY2006 · CA · contact PI